JP Morgan Maintains Neutral on DexCom, Raises Price Target to $82

Benzinga Newsdesk www.benzinga.com Neutral 56.8%

Neg 0% Neu 56.8% Pos 0%

JP Morgan analyst Robbie Marcus maintains DexCom (NASDAQ:DXCM) with a Neutral and raises the price target from $65 to $82.